Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.
In a new study presented at CROI 2023, researchers examined how depression and anxiety in individuals with HIV impacts the risk of incident acute myocardial infarction in this patient population.
The use of mindfulness-based treatments for individuals with anxiety disorders is as effective as a common antidepressant medication, according to the authors of a recent study.
In a recent meta-analysis and systematic review, researchers examined prevalence of relapse and characteristics that influence relapse risk among patients with anxiety disorders who discontinued...
Although multiple treatment options for childhood anxiety exist, current guidelines do not provide consistent advice on which to use. In a recent study, researchers assessed the safety and efficacy of...
